SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-018449
Filing Date
2024-04-08
Accepted
2024-04-08 06:04:00
Documents
14
Period of Report
2024-04-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20026226_8k.htm   iXBRL 8-K 26242
2 EXHIBIT 99.1 ef20026226_ex99-1.htm EX-99.1 33298
  Complete submission text file 0001140361-24-018449.txt   203046

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20240407.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20240407_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20240407_pre.xml EX-101.PRE 16050
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20026226_8k_htm.xml XML 4072
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 24828010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)